当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Imed Ben Jeddou
Alzheimer's sickness has convoluted the execution of the new medical services change regulation on the grounds that the rate of the illness has been expanding in stunning extents, with no known therapy or fix. We are already adding millions of uninsured patients to the health care system, and Alzheimer's patients are making it more expensive to provide all Americans with outcome-oriented health care. For patients who have been diagnosed with that dreaded illness, there are no accepted "standard of care treatments." The sixth leading cause of death in the United States is Alzheimer's disease, which currently affects an estimated 5.4 million people. It is assessed that somebody in America fosters the sickness like clockwork and by mid-century somebody will foster Alzheimer's like clockwork. Observing an Alzheimer's patient's advancement is significant, since recognizing the objective parts of their physical and mental deterioration, is a fundamental component in the evaluation of their recovery result factors and useful freedom. Alzheimer's disease does not just affect the elderly; people in their 30s, 40s, and 50s can get the disease. Finding a method that is objective and can accurately reflect an Alzheimer's patient's happiness could be beneficial for the patient's health as a whole. The Primary Caregiver Rating Index and the Patient Happiness Indicator have been proposed as methods for evaluating one crucial aspect of an Alzheimer's patient's day-to-day functioning and keeping track of their relative happiness.